School of Medicine
Showing 8,261-8,280 of 13,039 Results
-
Varalakshmi Niranjan, MD, MBA, Dip ABLM, Dip ABOM
Clinical Associate Professor, Medicine - Primary Care and Population Health
BioDr. Varalakshmi Niranjan is triple boarded in Internal Medicine, Obesity Medicine, Lifestyle Medicine and an Author, practicing with Stanford healthcare. Dr. Niranjan practices obesity medicine and lifestyle medicine. Her clinical focus is on prevention and management of chronic diseases including Diabetes Mellitus, Hypertension, Obesity and Chronic Kidney Disease. She is the Founder and Program Director of Cardio metabolic and Lifestyle Medicine program called SMILES - Stanford Metabolic Intervention with Lifestyle Empowerment Support Group.
She is the clinical lead for the ICDP (Improvement Capability Development Program), a joint venture between the Department of Quality for Stanford Healthcare and the Stanford School of Medicine on the management of obesity. She is also the clinical lead for VBC (Value based care) project on MASLD (Metabolic Associated Steatotic Liver Disease) Dr. Niranjan has a special interest in global public health and has conducted a variety of health awareness and wellness camps in rural India.
Dr. Niranjan was the Regional Medical Director of population health for Saint Francis Healthcare Partners in Hartford, Connecticut before joining Stanford University. In her administrative role, she led many projects to improve patient safety and quality. Her research interests include ways to facilitate the teaching of lifestyle medicine, for which she received a Kaiser grant. She also received Food as Medicine Essentials Grant to implement Lifestyle Medicine education for the medical and ancillary staff at the University of Connecticut. She conducts workshops nationwide to teach primary care providers how to manage obesity with lifestyle interventions and medications. She also wrote a guidebook that offers a step-by-step approach for providers to help their patients manage obesity.
Dr. Niranjan has published her work in many peer-reviewed journals, including International Journal of Clinical Practice, Obesity Pillars, and Journal of General Internal Medicine. She is a reviewer for Obesity Pillars and Journal of Brown Hospital Medicine and has presented her work at professional meetings and conferences nationwide. In addition, she has authored several books and e-books, including a health education book and an e-cookbook of vegetarian soups for weight loss.
Dr. Niranjan is a fellow of the American College of Physicians and the Obesity Medicine Association. She is also a member of the American College of Lifestyle Medicine and Society of General Internal Medicine. -
Jeff Nirschl
Affiliate, Biomedical Data Science
BioJeff Nirschl, M.D., Ph.D. is an Instructor in Pathology at Stanford University, Stanford, CA with clinical expertise in Neuropathology. He completed his Ph.D. in Neuroscience at the University of Pennsylvania under the supervision of Dr. Erika Holzbaur. During his thesis research, he investigated axonal transport and genetic forms of parkinsonism. He also developed computational image analysis workflows for fluorescence microscopy and digital pathology. His research interests include molecular motors and the neuronal cytoskeleton, the regulation of axonal transport in neurodegeneration, digital pathology, and quantitative image analysis using machine learning.
https://orcid.org/0000-0001-6857-341X -
Dwight Nishimura
Addie and Al Macovski Professor, Emeritus
Current Research and Scholarly Interestsmedical imaging, magnetic resonance imaging
-
Seiji Nishino
Professor (Research) of Psychiatry & Behavioral Sciences, Emeritus
Current Research and Scholarly InterestsThe research focus of the Sleep and Circadian Neurobiology (SCN) Laboratory is the study of the sleep and circadian physiology using various animal models. A portion of the research is carried out using rodent models of narcolepsy and circadian rhythm sleep disorders. The laboratory also carries out pharmacological studies aiming to develop new treatments for these sleep disorders.
-
Ryan Nitta
Sr Res Scientist-Basic Life, Neurosurgery
Current Role at StanfordThe main project of the Li lab is to elucidate the signaling pathways responsible for maintaining and initiating brain tumor growth. Previously the Li lab has identified an interesting protein, known as casein kinase 2, which plays an integral role in adult brain tumor growth. My goal is to expand on this initial finding and determine if casein kinase 2 could be a therapeutically relevant drug target in adult brain tumors and whether this protein plays a role in pediatric brain tumors. The role of the candidate would be the lead researcher on these projects, as well as managing and leading the undergraduate and medical students in the lab. In addition, I am responsible for maintaining the laboratory and assisting in grant writing.
-
Joyce Njoroge, MD
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioDr. Njoroge is a board-certified physician and fellowship-trained cardiologist with the Advanced Heart Failure Program at Stanford Health Care. She is also a clinical assistant professor of medicine in the Division of Cardiovascular Medicine.
Dr. Njoroge has extensive clinical experience diagnosing and treating cardiovascular complications that develop during pregnancy or postpartum. She currently provides care at the Stanford Health Care Heart and Vascular Clinic with a particular focus on patients with a history of pregnancy-associated heart failure and cardiomyopathy.
Dr. Njoroge’s research efforts involve identifying inherited genetic changes and biological markers that could help improve screening and care for pregnant women in higher risk populations. This includes determining the causes of disproportionately high incidences of heart-related complications and deaths experienced by Black women during and after pregnancy. Dr. Njoroge is also currently recruiting patients for a large-scale, multicenter clinical trial evaluating a drug to treat cardiovascular complications during pregnancy.
Dr. Njoroge has published her work in numerous prestigious peer-reviewed journals, including Circulation Research and the Journal of Cardiac Failure. She also co-authored a chapter on cardiovascular disease in pregnancy in the most recent edition of the book Current Diagnosis and Treatment: Cardiology.
Dr. Njoroge is a member of the Association of Black Cardiologists, the American College of Cardiology, the American Heart Association, and the Heart Failure Society of America. -
Chloe Nobuhara
Masters Student in Epidemiology and Clinical Research, admitted Autumn 2025
BioDr. Chloe Nobuhara is a Stanford general surgery resident and AI researcher dedicated to upholding patient safety standards while pursing aggressive surgical innovation. Currently on a two-year professional development track during residency, her research explores the intersection of AI and surgical practice. She has collaborated with the Medical AI and Computer Vision (MARVL) Lab to use computer vision and vision language models for performance assessment, worked with the Operating Room Black Box technologies for ambient intelligence and automated documentation, and most recently is helping to organize a foreign body identification challenge for MICCAI.
Dr. Nobuhara holds an MD from Duke University and an undergraduate degree from Northeastern University. Originally hailing from Honolulu, Hawaii, she brings a global perspective to her work, having flown over 100,000 miles (4x around the globe) for speaking engagements and conferences during her research time. -
Julia E. Noel, MD
Clinical Assistant Professor (Affiliated), OHNS/Head & Neck Surgery Divisions
Staff, OHNS/Otolaryngology/Head & Neck SurgeryBioDr. Noel is a head and neck surgeon with fellowship training in endocrine surgery, specializing in surgery of the thyroid and parathyroid gland and lymph nodes. She is the chief of Otolaryngology Head & Neck Surgery at Santa Clara Valley Medical Center and an affiliate assistant professor in the Stanford School of Medicine.
Among the many conditions she treats are thyroid cancer, thyroid nodules, hyperthyroidism, hyperparathyroidism, hypercalcemia, Grave’s disease, and goiter. She has expertise and training in minimally invasive treatment approaches and ultrasound-guided techniques performed in the office, such as radiofrequency ablation (RFA) and alcohol ablation.
For every patient, Dr. Noel prepares a personalized care plan that is comprehensive and compassionate. Her goal is to educate and empower each patient to achieve the best possible health and quality of life. Patient reviews praise her clinical expertise as well as her skills as a listener and communicator.
Dr. Noel conducts a robust research program to advance patient care. She has published extensively on the diagnosis, appropriate management, and optimization of outcomes for patients with thyroid and parathyroid disorders. Her articles have appeared in JAMA Otolaryngology Head and Neck Surgery, Nature Communications, Endocrine Practice, and many more peer-reviewed journals. She has co-authored numerous guideline and consensus statements, including an international statement on the use of RFA in benign and malignant thyroid nodules. She is an editorial board member for VideoEndocrinology, a video journal covering leading-edge diagnostic and treatment techniques and technologies, and has served as an associate editor for Laryngoscope Investigative Otolaryngology.
Dr. Noel has made presentations to her peers at national and international meetings of the American Academy of Otolaryngology, Head & Neck Surgery, American Thyroid Association, American Head & Neck Society, and the World Congress of Thyroid Cancer. She also has shared her insights into the future of thyroid surgery at the International Thyroid Cancer Survivors’ Conference.
She is a member of the American Academy of Otolaryngology and Head and Neck Surgery, American Head and Neck Society, American Thyroid Association, American College of Surgeons, and the North American Society for Interventional Thyroidology, of which she has served on the executive council since 2023.